Screening compound: VKLHIQPYRSTIAK-UHFFFAOYSA-N

Screening compound: VKLHIQPYRSTIAK-UHFFFAOYSA-N
Screening compound: VKLHIQPYRSTIAK-UHFFFAOYSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
VKLHIQPYRSTIAK-UHFFFAOYSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M136-0370

Molecular Formula

C25H23ClN6O2 (C25 H23 ClN6 O2)

Compound Name

1-{3-[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]pyridin-2-yl}-N-[(pyridin-2-yl)methyl]piperidine-4-carboxamide

IUPAC name

1-{3-[3-(4-chlorophenyl)-124-oxadiazol-5-yl]pyridin-2-yl}-N-[(pyridin-2-yl)methyl]piperidine-4-carboxamide

SMILES

O=C(C(CC1)CCN1c(nccc1)c1-c1nc(-c(cc2)ccc2Cl)no1)NCc1ncccc1

InChI

InChI=1S/C25H23ClN6O2/c26-19-8-6-17(7-9-19)22-30-25(34-31-22)21-5-3-13-28-23(21)32-14-10-18(11-15-32)24(33)29-16-20-4-1-2-12-27-20/h1-9,12-13,18H,10-11,14-16H2,(H,29,33)

InChI Key

VKLHIQPYRSTIAK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27532128

VKLHIQPYRSTIAK-UHFFFAOYSA-N in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

Hsp90-Targeted Library (11355 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • Receptor's ligands
Structure:
  • Mimetics
Targets:
  • Proteases
  • GPCR

References: we are preparing a list of scientific research reports with VKLHIQPYRSTIAK-UHFFFAOYSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound VKLHIQPYRSTIAK-UHFFFAOYSA-N?
Check Price and Availability of VKLHIQPYRSTIAK-UHFFFAOYSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of VKLHIQPYRSTIAK-UHFFFAOYSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for VKLHIQPYRSTIAK-UHFFFAOYSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for VKLHIQPYRSTIAK-UHFFFAOYSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of VKLHIQPYRSTIAK-UHFFFAOYSA-N available by request